Fibroblast growth factor 23 (FGF23), another hormonal mediator, also participates in phosphorus regulation in order to match bone mineralization, counteracts the effects of vitamin D, and plays a key role in malignancy-induced hypophosphatemia [3,4]. Here, FGF23 is linked to hypophosphatemia.